Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Primary Cutaneous Anaplastic Large Cell

Explore clinical trials studying Lymphoma, Primary Cutaneous Anaplastic Large Cell. Study availability and eligibility vary by location and protocol.

9 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Lymphoma, Primary Cutaneous Anaplastic Large Cell trial results

Recruiting

A Registry for People With T-cell Lymphoma

NCT05978141

Conditions
Adult T-Cell Leukemia/Lymphoma, Aggressive NK-cell Leukemia, Anaplastic Large Cell Lymphoma, ALK-Positive, +54 more
Locations
  • City of Hope Cancer Center (Data collection only) Duarte, California, United States
  • UNIVERSITY OF CALIFORNIA SAN DIEGO (Data collection only) San Diego, California, United States
  • University of California San Francisco (Data collection only) San Francisco, California, United States
  • Stanford University Medical Center (Data collection only) Stanford, California, United States
View all 26 locations
View Trial Details
Completed

A Phase 3 Trial of Brentuximab Vedotin(SGN-35) Versus Physician's Choice (Methotrexate or Bexarotene) in Participants With CD30-Positive Cutaneous T-Cell Lymphoma (ALCANZA Study)

NCT01578499

Conditions
Cutaneous T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations
  • Los Angeles, California, United States
  • Palo Alto, California, United States
  • Chicago, Illinois, United States
  • Boston, Massachusetts, United States
View all 41 locations
View Trial Details
Completed

Pralatrexate and Bexarotene in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma

NCT01134341

Conditions
Cutaneous T-Cell Lymphoma, Disease Attributes, Hemic and Lymphatic Diseases, +17 more
Locations
  • Stanford University School of Medicine Stanford, California, United States
  • Memorial Sloan-Kettering Cancer Center New York, United States
  • University of Pittsburgh School of Medicine Pittsburgh, Pennsylvania, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Completed

Study of SGN-30 (Anti-CD30 mAb) in Patients With Primary Cutaneous Anaplastic Large Cell Lymphoma

NCT00099255

Conditions
Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, Histiocytic Disorders, Malignant, +14 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of California at Los Angeles Los Angeles, California, United States
  • Stanford University Stanford, California, United States
  • Yale New Haven, Connecticut, United States
View all 13 locations
View Trial Details
Active, Not Recruiting

Cholecalciferol in Improving Survival in Patients With Newly Diagnosed Cancer With Vitamin D Insufficiency

NCT01787409

Conditions
Aggressive Non-Hodgkin Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +40 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Emory University/Winship Cancer Institute Atlanta, Georgia, United States
  • University of Iowa/Holden Comprehensive Cancer Center Iowa City, Iowa, United States
  • Mayo Clinic Rochester, Minnesota, United States
View Trial Details

Related conditions